[144] SCANSOURCE, INC. SEC Filing

Rhea-AI Filing Summary

ScanSource, Inc. (SCSC) reported a Form 144 notice for the proposed sale of 150,000 common shares, with an aggregate market value of $6,743,966.40, to be sold on or about 09/17/2025 through Merrill Lynch on the NASDAQ. The filing lists 21,884,508 shares outstanding, indicating the shares to be sold represent about 0.69% of outstanding stock.

All 150,000 shares were acquired from ScanSource, Inc. as compensatory awards: 2,618 and 122,382 shares from exercises dated 09/17/2025, and vested awards of 2,451 (08/26/2024), 14,872 (08/25/2025) and 7,677 (08/26/2025). The filer states no sales by the person in the prior three months and certifies no undisclosed material adverse information.

Positive

• Full disclosure of acquisition dates and amounts for all 150,000 shares, showing consistency between acquired and to-be-sold shares
• Sale to be executed through a major broker (Merrill Lynch) on NASDAQ, providing execution transparency
• Filer certifies no undisclosed material information in connection with the proposed sale

Negative

• Insider sale size equals 150,000 shares (~0.69% of outstanding shares), which could exert modest selling pressure on the market on the sale date

Insights

Securities Analyst

TL;DR: This is a routine insider sale of compensatory stock awards totaling 150,000 shares, representing about 0.69% of outstanding shares.

The filing shows all shares were acquired from the issuer as compensation via exercises and vesting, and will be sold through Merrill Lynch on NASDAQ on or about 09/17/2025. There are no reported sales by the filer in the prior three months, which suggests this is a planned disposal of recently acquired awards rather than an ongoing disposition. The aggregate market value stated is $6,743,966.40, which helps quantify potential market impact but remains a small fraction of total outstanding shares. Documentation includes the required representation regarding material nonpublic information.

Corporate Governance Expert

TL;DR: Transaction appears to be standard compensation-related disposition with required certifications; no governance red flags disclosed.

All securities were acquired as compensatory stock awards from ScanSource, Inc., with acquisition and payment dates listed. The filer affirms absence of undisclosed material information and the form notes compliance with Rule 144 disclosure requirements. There is no indication of trading-plan adoption date on the face of the form, and the filer reports no related sales in the last three months. Based solely on the filing, this disclosure aligns with routine insider liquidity events and standard compliance statements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3455 Peachtree Rd NE Ste 1000 Atlanta GA 30326	150000	6743966.4	21884508	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/17/2025	Exercise of a Stock Award	ScanSource, Inc			2618	09/17/2025	Compensatory Payment
Common	09/17/2025	Exercise of a Stock Award	ScanSource, Inc			122382	09/17/2025	Compensatory Payment
Common	08/26/2024	Vesting of a Stock Award	ScanSource, Inc			2451	08/26/2024	Compensatory Payment
Common	08/25/2025	Vesting of a Stock Award	ScanSource, Inc			14872	08/25/2025	Compensatory Payment
Common	08/26/2025	Vesting of Stock Awards	ScanSource, Inc			7677	08/26/2025	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is the size and value of the proposed insider sale by SCSC?

The filer proposes to sell 150,000 common shares with an aggregate market value of $6,743,966.40 (approximate sale date 09/17/2025).

Through which broker and exchange will the SCSC shares be sold?

The sale is to be executed through Merrill Lynch (3455 Peachtree Rd NE, Atlanta, GA) on the NASDAQ.

How were the 150,000 SCSC shares acquired?

All shares were acquired from ScanSource, Inc. as compensatory stock awards via exercises and vesting on dates listed in the filing.

Do these sales follow any reported transactions in the past three months?

The filing reports "Nothing to Report" for securities sold by the person in the past three months.

What percentage of ScanSource outstanding shares does this sale represent?

The sale represents about 0.69% of the reported 21,884,508 shares outstanding.

Does the filing indicate any undisclosed material information?

By signing the notice, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.